# Effect of Acetazolamide on Subclinical High-Altitude Pulmonary Edema Detected by Lung Ultrasonography

> **NCT03490916** · PHASE4 · TERMINATED · sponsor: **Vincent Kan** · enrollment: 18 (actual)

## Conditions studied

- High Altitude Pulmonary Edema

## Interventions

- **DRUG:** Acetazolamide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03490916
- **Lead sponsor:** Vincent Kan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-03-23
- **Primary completion:** 2018-04-04
- **Final completion:** 2018-04-04
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** PI was unable to continue to gather data during the trip during to medical illness
- **Last updated:** 2019-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03490916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03490916, "Effect of Acetazolamide on Subclinical High-Altitude Pulmonary Edema Detected by Lung Ultrasonography". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03490916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
